Joseph Khoury
Angle has appointed Joseph Khoury to its scientific advisory board. Khoury currently serves as a tenured professor of pathology and laboratory medicine at the University of Texas MD Anderson Cancer Center.
Benjamin Reed, James Fullerton-Batten, Nick Ash, Matt Pomroy
Epistem has completed its board appointments: Benjamin Reed will join as commercial director — he had previously served as Epistem's pharmacogenomics business development director; James Fullerton-Batten joins the board from Concept Life Sciences, where he served as finance director; Nick Ash joins the board from Source BioScience, where he served as CEO; and Matt Pomroy joins the board as a non-executive investor representative from Foresight Group.
Reginald Seeto
CareDx has appointed Reginald Seeto to the newly created role of president and chief business officer. Seeto has 20 years of experience in commercial operations, corporate development, and strategy, most recently serving as chief operating officer at Ardelyx. He has also worked at AstraZeneca/Medimmune and was a member of the MedImmune executive team. His responsibilities there included leading corporate development and strategy, global strategic marketing, and portfolio management for all therapeutic areas, as well as a country leadership role at AstraZeneca in Thailand. Before AstraZeneca, Seeto held positions at Organon Biosciences and at McKinsey.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.